Page 74 - MASALA Magazine Vol.15 Issue 8 | December - January 2025
P. 74

UROLIFT






                The Non-Surgical

            Treatment for Benign

            Prostatic Hyperplasia                                       What is Benign Prostatic Hyperplasia (BPH)?

                                                                        Benign Prostatic Hyperplasia (BPH) is a prevalent
                              (BPH)                                     condition among aging men, often impacting their
                                                                        daily lives. It is particularly associated with urinary tract
                                                                        symptoms, such as urinary retention and increased
                                                                        frequency of urination, which can be both distressing
                                            The prostate is a gland     to overall quality of life.
                                            that produces fluid         Incomplete urination or post-void dribbling, urine leakage
                                            essential for nourishing    and insuf cient bladder emptying, can complicate the

                                            sperm during its journey    management of urinary tract conditions. Traditional
                                            through the female          treatments, such as injections or thermal ablation
                                            reproductive system.        techniques, may have limitations and potential side
                                            As men age, typically       effects. However, the Urolift system offers an innovative,
                                            from around 40 years,       minimally invasive approach that eliminates the need
                                            the prostate undergoes      for surgical intervention.
                                            tissue changes that can
                                            lead to benign prostatic    Currently, the Urolift system is recognised as one of the
                                            hyperplasia (BPH). By       most effective advancements in the non-surgical treatment
           the age of 45, most men will experience some degree of prostate   of benign prostatic hyperplasia (BPH). Approved by the
           enlargement, and with advancing age, it is common for nearly all   US Food and Drug Administration (FDA) since 2013,
            men to develop this condition. Dr Danaiphand Akarasakul, M.D.,   this procedure involves inserting a camera through the
           a urology specialist at Sukumvit Hospital, shares his insights on   urethra to access the prostate without relying on heat
           an effective treatment for enlarged prostates. This treatment   to destroy tissue. Urolift provides rapid and safe relief
           does not require hospitalisation, allowing patients to undergo   from prostate enlargement, allowing patients to resume
           the procedure and return home immediately.                   normal activities or work within 1 to 3 days.
   69   70   71   72   73   74   75   76   77   78   79